| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 830 | 415 | 0 | 0 |
| Category | Amount |
|---|---|
| NONE | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| EXIQON - 5,678 SHS | 0 | 0 |
| EXIQON - 2,312 SHS | 0 | 0 |
| VIASAT - 400 SHS | 0 | 0 |
| VIASAT - 50 SHS | 0 | 0 |
| SANFORD C. BERNSTEIN & CO. | 407,884 | 445,030 |
| SURRO IMMUNOLOGY | 955 | 995 |
| SILENSEED, LTD - 709 SHS | 31,875 | 31,875 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT MGMT EXPENSE | 4,432 | 4,432 | 0 | 0 |
| SURRO IMMUNOLOGY K-1 | 231 | 231 | 0 | 0 |
| MISCELLANEOUS EXPENSE | 18 | 18 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES PAID | 115 | 115 | 0 | 0 |
| STATE TAXES | 10 | 10 | 0 | 0 |